{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:23:05Z","timestamp":1779297785858,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zymosan, a natural compound, provokes acute peritonitis and multiple organ dysfunction that affects the kidney, beside other organs via exaggerated inflammatory response. The aim of the present study is to test the role of cholinergic anti-inflammatory pathway (CAP) in alleviating acute kidney injury (AKI) induced by zymosan in BALB\/c mice, using galantamine, a cholinesterase inhibitor, known to act via \u03b17 nicotinic acetylcholine receptor (\u03b17 nAChR) to stimulate CAP. Galantamine verified its anti-inflammatory effect by elevating acetylcholine (ACh) level, while abating the interleukin-6\/\u00a0janus kinase 2 (Y1007\/1008)\/\u00a0signal transducer and activator of transcription 3 (Y705) (IL-6\/ pY(1007\/1008)-JAK2\/ pY705-STAT3) inflammatory axis, with a consequent inhibition in suppressor of cytokine signaling 3 (SOCS3). This effect entails also the nuclear factor-kappa B (p65)\/\u00a0high mobility group box protein-1\/ (NF-\u03baB (p65)\/ HMGB-1) signaling pathway. Furthermore, the reno-curattive effect of galantamine was associated by a reduction in plasma creatinine (Cr), cystatin (Cys)-C, IL-18, and renal neutrophil gelatinase-associated lipocalin (NGAL), as well as an improved histopathological structure. Blocking the \u03b17 nAChR by methyllycaconitine abolished the beneficial effect of galantamine to document the involvement of this receptor and the CAP in the amelioration of AKI induced by zymosan.<\/jats:p>","DOI":"10.1038\/s41598-018-35254-1","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T16:23:02Z","timestamp":1541694182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Activation of \u03b17 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB\/c Mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Sherehan M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Y.","family":"Al-Shorbagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalaal M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan S.","family":"El-Abhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"35254_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720510790274455","volume":"7","author":"T Darreh-Shori","year":"2010","unstructured":"Darreh-Shori, T. & Soininen, H. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer\u2019s disease: a review of recent clinical studies. Current Alzheimer Research 7, 67\u201373 (2010).","journal-title":"Current Alzheimer Research"},{"key":"35254_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-2999(00)00093-5","volume":"393","author":"A Maelicke","year":"2000","unstructured":"Maelicke, A. & Albuquerque, E. X. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer\u2019s disease. European Journal of Pharmacology 393, 165\u2013170 (2000).","journal-title":"European Journal of Pharmacology"},{"key":"35254_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","volume":"23","author":"VA Pavlov","year":"2009","unstructured":"Pavlov, V. A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain, Behavior and Immunity 23, 41\u201345 (2009).","journal-title":"Brain, Behavior and Immunity"},{"key":"35254_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey, K. J. The inflammatory reflex. Nature. 420, 853\u2013859 (2002).","journal-title":"Nature."},{"key":"35254_CR5","doi-asserted-by":"publisher","first-page":"e0134648","DOI":"10.1371\/journal.pone.0134648","volume":"10","author":"MA Ali","year":"2015","unstructured":"Ali, M. A., El-Abhar, H. S., Kamel, M. A. & Attia, A. S. Antidiabetic effect of galantamine: Novel effect for a known centrally acting drug. PLoS ONE 10, e0134648 (2015).","journal-title":"PLoS ONE"},{"key":"35254_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ejphar.2015.07.038","volume":"764","author":"MA Gowayed","year":"2015","unstructured":"Gowayed, M. A., Refaat, R., Ahmed, W. M. & El-Abhar, H. S. Effect of galantamine on adjuvant-induced arthritis in rats. European Journal of Pharmacology 764, 547\u2013553 (2015).","journal-title":"European Journal of Pharmacology"},{"key":"35254_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23359-6","volume":"8","author":"SA Wazea","year":"2018","unstructured":"Wazea, S. A., Wadie, W., Bahgat, A. K. & El-Abhar, H. S. Galantamine anti-colitic effect: Role of alpha-7 nicotinic acetylcholine receptor in modulating Jak\/STAT3, NF-\u03baB\/HMGB1\/RAGE and p-AKT\/Bcl-2 pathways. Scientific Reports 8, 5110, https:\/\/doi.org\/10.1038\/s41598-018-23359-6 (2018).","journal-title":"Scientific Reports"},{"key":"35254_CR8","first-page":"OA282","volume":"50","author":"RS Fernanda Paula","year":"2017","unstructured":"Fernanda Paula, R. S. et al. Nicotinic alpha-7 receptor stimulation (\u03b17nAChR) inhibited NF-kB\/STAT3\/SOCS3 pathways in a murine model of asthma. European Respiratory Journal 50, OA282 (2017).","journal-title":"European Respiratory Journal"},{"key":"35254_CR9","first-page":"1303","volume":"2","author":"D Basile","year":"2012","unstructured":"Basile, D., Anderson, M. & Sutton, T. Pathophysiology of Acute Kidney Injury. Comprehensive. Physiology 2, 1303\u20131353 (2012).","journal-title":"Physiology"},{"key":"35254_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrneph.2014.180","volume":"11","author":"HR Jang","year":"2015","unstructured":"Jang, H. R. & Rabb, H. Immune cells in experimental acute kidney injury. Nature Reviews. Nephrology 11, 88\u2013101 (2015).","journal-title":"Nature Reviews. Nephrology"},{"key":"35254_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-immunol-030409-101311","volume":"28","author":"KL Rock","year":"2010","unstructured":"Rock, K. L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annual Review of Immunology 28, 321\u2013342 (2010).","journal-title":"Annual Review of Immunology"},{"key":"35254_CR12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts, C., Panzer, U., Anders, H. J. & Rees, A. J. The immune system and kidney disease: basic concepts and clinical implications. Nature Reviews. Immunology 13, 738\u2013753 (2013).","journal-title":"Nature Reviews. Immunology"},{"key":"35254_CR13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/archsurg.1986.01400080039006","volume":"121","author":"RJ Goris","year":"1986","unstructured":"Goris, R. J., Boekholtz, W. K., van Bebber, I. P., Nuytinck, J. K. & Schillings, P. H. Multiple-organ failure and sepsis without bacteria. An experimental model. Archives of Surgery 121, 897\u2013901 (1986).","journal-title":"Archives of Surgery"},{"key":"35254_CR14","first-page":"291","volume":"23","author":"TJ Volman","year":"2005","unstructured":"Volman, T. J., Hendriks, T. & Goris, R. J. Studies Into Mechanisms Leading To Multiple. Organ 23, 291\u2013297 (2005).","journal-title":"Organ"},{"key":"35254_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-6-13","volume":"6","author":"P Dimitrova","year":"2009","unstructured":"Dimitrova, P., Gyurkovska, V., Shalova, I., Saso, L. & Ivanovska, N. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490. Journal of Inflammation 6, 13 (2009).","journal-title":"Journal of Inflammation"},{"key":"35254_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/SHK.0b013e3181def9aa","volume":"34","author":"K Xie","year":"2010","unstructured":"Xie, K. et al. Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock 34, 495\u2013501 (2010).","journal-title":"Shock"},{"key":"35254_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-7-12","volume":"7","author":"M Galuppo","year":"2010","unstructured":"Galuppo, M. et al. Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study. Journal of Inflammation 7, 12 (2010).","journal-title":"Journal of Inflammation"},{"key":"35254_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/SHK.0000000000000502","volume":"45","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. The Protective Role of Curcumin in Zymosan-Induced Multiple Organ Dysfunction Syndrome in Mice. Shock 45, 209\u2013219 (2016).","journal-title":"Shock"},{"key":"35254_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson, U. & Tracey, K. J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 29, 139\u201362 (2011).","journal-title":"Annu Rev Immunol."},{"key":"35254_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang, H. et al. HMG-1 as a Late Mediator of Endotoxin Lethality in Mice. Science. 285, 248\u2013251 (1999).","journal-title":"Science."},{"key":"35254_CR21","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.3748\/wjg.v21.i38.10853","volume":"21","author":"YM Li","year":"2015","unstructured":"Li, Y. M. et al. Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction. World Journal of Gastroenterology 21, 10853\u201310865 (2015).","journal-title":"World Journal of Gastroenterology"},{"key":"35254_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2119\/molmed.2011.00083","volume":"17","author":"SK Satapathy","year":"2011","unstructured":"Satapathy, S. K. et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Molecular medicine 17, 599\u2013606 (2011).","journal-title":"Molecular medicine"},{"issue":"21","key":"35254_CR23","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1523\/JNEUROSCI.0027-07.2007","volume":"27","author":"M Solinas","year":"2007","unstructured":"Solinas, M. et al. Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 27(21), 5615\u20135620 (2007).","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"35254_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"35254_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1476-5381.2011.01248.x","volume":"163","author":"B Rinaldi","year":"2011","unstructured":"Rinaldi, B. et al. PPAR\u03b1 mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure. British Journal of Pharmacology 163, 609\u2013623 (2011).","journal-title":"British Journal of Pharmacology"},{"key":"35254_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ni0710-561","volume":"11","author":"KJ Tracey","year":"2010","unstructured":"Tracey, K. J. Understanding immunity requires more than immunology. Nature Immunology 11, 561\u2013564 (2010).","journal-title":"Nature Immunology"},{"key":"35254_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0006-3223(00)01109-4","volume":"49","author":"A Maelicke","year":"2001","unstructured":"Maelicke, A. et al. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer\u2019s disease. Biological Psychiatry 49, 279\u2013288 (2001).","journal-title":"Biological Psychiatry"},{"key":"35254_CR28","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.3390\/ijms15069809","volume":"15","author":"M Pohanka","year":"2014","unstructured":"Pohanka, M. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. International Journal of Molecular Sciences 15, 9809\u20139825 (2014).","journal-title":"International Journal of Molecular Sciences"},{"key":"35254_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"LV Borovikova","year":"2000","unstructured":"Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458\u2013462 (2000).","journal-title":"Nature"},{"key":"35254_CR30","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.23987","volume":"58","author":"JM Waldburger","year":"2008","unstructured":"Waldburger, J. M., Boyle, D. L., Pavlov, V. A., Tracey, K. J. & Firestein, G. S. Acetylcholine regulation of synoviocyte cytokine expression by the \u03b17 nicotinic receptor. Arthritis and Rheumatism 58, 3439\u20133449 (2008).","journal-title":"Arthritis and Rheumatism"},{"key":"35254_CR31","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.4049\/jimmunol.170.6.3263","volume":"170","author":"C Niemand","year":"2003","unstructured":"Niemand, C. et al. Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3. The Journal of Immunology 170, 3263\u20133272 (2003).","journal-title":"The Journal of Immunology"},{"key":"35254_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1681\/ASN.2007070744","volume":"19","author":"Y Nechemia-Arbely","year":"2008","unstructured":"Nechemia-Arbely, Y. et al. IL-6\/IL-6R axis plays a critical role in acute kidney injury. J.Am.Soc.Nephrol. 19, 1106\u20131115 (2008).","journal-title":"J.Am.Soc.Nephrol."},{"key":"35254_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ndt\/gfm509","volume":"23","author":"N Yang","year":"2008","unstructured":"Yang, N. et al. Blockage of JAK\/STAT signalling attenuates renal ischaemia-reperfusion injury in rat. Nephrology Dialysis Transplantation 23, 91\u2013100 (2008).","journal-title":"Nephrology Dialysis Transplantation"},{"key":"35254_CR34","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/eji.201040540","volume":"40","author":"G Pe\u00f1a","year":"2010","unstructured":"Pe\u00f1a, G. et al. Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis. European Journal of Immunology 40, 2580\u20132589 (2010).","journal-title":"European Journal of Immunology"},{"key":"35254_CR35","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/cr.2013.116","volume":"23","author":"Y Sun","year":"2013","unstructured":"Sun, Y. et al. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Research 23, 1270\u20131283 (2013).","journal-title":"Cell Research"},{"key":"35254_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/cr.2013.128","volume":"23","author":"L Ulloa","year":"2013","unstructured":"Ulloa, L. The cholinergic anti-inflammatory pathway meets microRNA. Cell Research 23, 1249\u20131250 (2013).","journal-title":"Cell Research"},{"key":"35254_CR37","doi-asserted-by":"publisher","first-page":"C1294","DOI":"10.1152\/ajpcell.00160.2009","volume":"297","author":"PK Chatterjee","year":"2009","unstructured":"Chatterjee, P. K., Al-Abed, Y., Sherry, B. & Metz, C. N. Cholinergic agonists regulate JAK2\/STAT3 signaling to suppress endothelial cell activation. American Journal of Physiology. Cell Physiology 297, C1294\u2013C1306 (2009).","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"35254_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/nm1124","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang, H. et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 10, 1216\u20131221 (2004).","journal-title":"Nature Medicine"},{"key":"35254_CR39","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/labinvest.3780116","volume":"80","author":"MM Sousa","year":"2000","unstructured":"Sousa, M. M., Yan, S. D., Stern, D. & Saraiva, M. J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Laboratory Investigation; a Journal of Technical Methods and Pathology 80, 1101\u20131110 (2000).","journal-title":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},{"key":"35254_CR40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/gast.2002.35391","volume":"123","author":"PL Sappington","year":"2002","unstructured":"Sappington, P. L. et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123, 790\u2013802 (2002).","journal-title":"Gastroenterology"},{"key":"35254_CR41","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1074\/jbc.M306793200","volume":"279","author":"JS Park","year":"2004","unstructured":"Park, J. S. et al. Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein. The Journal of Biological Chemistry 279, 7370\u20137377 (2004).","journal-title":"The Journal of Biological Chemistry"},{"key":"35254_CR42","doi-asserted-by":"publisher","first-page":"F1014","DOI":"10.1152\/ajprenal.00620.2012","volume":"305","author":"F Matsui","year":"2013","unstructured":"Matsui, F., Rhee, A., Hile, K. L., Zhang, H. & Meldrum, K. K. IL-18 induces profibrotic renal tubular cell injury via STAT3 activation. American Journal of Physiology - Renal Physiology 305, F1014\u2013F1021 (2013).","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"35254_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/14712598.7.1.31","volume":"7","author":"M Bombardieri","year":"2007","unstructured":"Bombardieri, M., McInnes, I. B. & Pitzalis, C. Interleukin-18 as a potential therapeutic target in chronic autoimmune\/inflammatory conditions. Expert Opin Biol Ther. 7, 31\u201340 (2007).","journal-title":"Expert Opin Biol Ther."},{"key":"35254_CR44","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI7317","volume":"104","author":"JA Gracie","year":"1999","unstructured":"Gracie, J. A. et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest. 104, 1393\u20131401 (1999).","journal-title":"J Clin Invest."},{"key":"35254_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/1529-0131(200102)44:2<275::AID-ANR44>3.0.CO;2-B","volume":"44","author":"M Yamamura","year":"2001","unstructured":"Yamamura, M. et al. Interferon-gamma inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum. 44, 275\u2013285 (2001).","journal-title":"Arthritis Rheum."},{"key":"35254_CR46","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.4049\/jimmunol.171.12.6630","volume":"171","author":"J Cowland","year":"2003","unstructured":"Cowland, J., Sorensen, O., Sehested, M. & Borregaard, N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol. 171, 6630\u20136639 (2003).","journal-title":"J Immunol."},{"key":"35254_CR47","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1038\/ajg.2010.23","volume":"105","author":"S Chakraborty","year":"2010","unstructured":"Chakraborty, S. et al. Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis. Am J Gastroenterol. 105, 2050\u20132059 (2010).","journal-title":"Am J Gastroenterol."},{"key":"35254_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1378\/chest.09-2718","volume":"138","author":"TM Eagan","year":"2010","unstructured":"Eagan, T. M. et al. Neutrophil gelatinaseassociated lipocalin: a biomarker in COPD. Chest 138, 888\u2013895 (2010).","journal-title":"Chest"},{"key":"35254_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2006080882","volume":"18","author":"KM Schmidt-Ott","year":"2007","unstructured":"Schmidt-Ott, K. M. et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 18, 407\u2013413 (2007).","journal-title":"J Am Soc Nephrol."},{"key":"35254_CR50","doi-asserted-by":"publisher","first-page":"14088","DOI":"10.1074\/jbc.M109.017129","volume":"285","author":"JR Karlsen","year":"2010","unstructured":"Karlsen, J. R., Borregaard, N. & Cowland, J. B. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-\u03b1 is controlled by I\u03baB-\u03b6 but neither by C\/EBP-\u03b2 nor C\/EBP-\u03b4. Journal of Biological Chemistry 285, 14088\u201314100 (2010).","journal-title":"Journal of Biological Chemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:32:18Z","timestamp":1671622338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35254-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16814"}}